"Quest's AD-Detect suite of advanced diagnostics has grown to include a range of validated blood-based biomarkers, giving providers options for personalizing testing for the individual patient," said ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

Quest Diagnostics unveiled a first-to-market blood test available for consumer purchase that helps assess the potential risk of developing Alzheimer’s disease. In adding AD-Detect, a single-blood-draw ...

Quest Diagnostics will soon begin offering a new blood-based in-vitro diagnostic test for Alzheimer’s. The disease affects nearly 7 million Americans. The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma ...

Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts. On June 10, the company said it is developing a Multi-Cancer Stratification (MCaST) ...

Quest Diagnostics will work on a blood test for cancer risk it says may help identify people who could benefit from more frequent screenings using technology developed at the MD Anderson Cancer Center ...

A cancer treatment laboratory in Lewisville recently made a medical breakthrough that could greatly decrease the risk of the ...

If you’re someone looking to be in the know about your health, the Watkins-Montour Rotary Club is offering a blood screening ...

Dr. Michael Racke, a neurologist and Medical Director of Neurology with Quest Diagnostics, speaks on Studio10 about Quest Diagnostic’s new blood test that can detect Alzheimer's. The test is a blood ...

CHICAGO, July 31 (Reuters) - Quest Diagnostics DGX.Non Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer's protein which can appear ...